Selective α7 nicotinic receptor agonists and positive allosteric modulators for the treatment of schizophrenia – a review
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2020.1764938
Abstract: ABSTRACT Introduction Alpha 7 nicotinic acetylcholine receptor (α7 nAChR) partial agonists, agonists, and positive allosteric modulators (PAMs) have been in development for over a decade. The initial candidates were in clinical trials for a wide… read more here.
Keywords: agonists positive; schizophrenia; nicotinic receptor; allosteric modulators ... See more keywords